Document is current
Any future updates will be listed below
-
Authors
Gumà, Josep https://orcid.org/0000-0001-7541-9832
Palazón-Carrión, Natalia
Rueda-Domínguez, Antonio
Sequero, Silvia
Calvo, Virginia
García-Arroyo, Ramón
Gómez-Codina, José
Llanos, Marta
Martínez-Banaclocha, Natividad
Provencio, Mariano
- License Information
-
More Information
Article History
Received: 25 September 2025
Accepted: 30 September 2025
First Online: 23 October 2025
Declarations
:
: JG has attended an advisory board for Incyte Biosciences and Kite-Gilead and has received other fees from Roche. ARD has received speaker fees and has attended an advisory board for Roche, BMS, MSD, Takeda, Merck, and Gilead. VC has attended an advisory board for Roche, BMS, AstraZeneca, and Boehringer Ingelheim; has received personal fees from Roche, BMS, MSD, AstraZeneca, Takeda, Lilly, and Boehringer Ingelheim; and has received speaker fees from BMS, MSD, AstraZeneca, Takeda, Pfizer, and Boehringer Ingelheim. ML has attended an advisory board for Incyte and has received speaker fees from Roche. MP has received speaker fees and has attended an advisory board for Roche and Takeda, and has attended an advisory board for Incyte. NPC, SS, RGA, JGC, and NMB declare that they have no conflicts of interest.
: Not applicable. The manuscript does not contain clinical studies or patient data.
